Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.

作者: Lin Tai-Shun , Raymond F. Schinazi , William H. Prusoff

DOI: 10.1016/0006-2952(87)90253-X

关键词:

摘要:

参考文章(27)
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro. The New England Journal of Medicine. ,vol. 313, pp. 1289- 1290 ,(1985) , 10.1056/NEJM198511143132011
Jan Balzarini, Rudi Pauwels, Piet Herdewijn, Erik De Clercq, David A. Cooney, Gil-Jong Kang, Maha Dalal, David G. Johns, Samuel Broder, Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine. Biochemical and Biophysical Research Communications. ,vol. 140, pp. 735- 742 ,(1986) , 10.1016/0006-291X(86)90793-X
T J Spira, L H Bozeman, R C Holman, D T Warfield, S K Phillips, P M Feorino, Micromethod for assaying reverse transcriptase of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Journal of Clinical Microbiology. ,vol. 25, pp. 97- 99 ,(1987) , 10.1128/JCM.25.1.97-99.1987
Erik De Clercq, Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). Journal of Medicinal Chemistry. ,vol. 29, pp. 1561- 1569 ,(1986) , 10.1021/JM00159A001
Jerome P. Horwitz, Jonathan Chua, Margaret A. Da Rooge, Michael Noel, Irwin L. Klundt, Nucleosides. IX. The formation of 2',2'-unsaturated pyrimidine nucleosides via a novel beta-elimination reaction. Journal of Organic Chemistry. ,vol. 31, pp. 205- 211 ,(1966) , 10.1021/JO01339A045
R F Schinazi, T C Chou, R T Scott, X J Yao, A J Nahmias, Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis. Antimicrobial Agents and Chemotherapy. ,vol. 30, pp. 491- 498 ,(1986) , 10.1128/AAC.30.3.491
Tai-Shun Lin, Raymond F. Sohinazi, Ming S. Chen, Elaine Kinney-Thomas, William H. Prusoff, Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro Biochemical Pharmacology. ,vol. 36, pp. 311- 316 ,(1987) , 10.1016/0006-2952(87)90287-5
David A. Cooney, Maha Dalal, Hiroaki Mitsuya, James B. McMahon, Mohan Nadkarni, Jan Balzarini, Samuel Broder, David G. Johns, Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity Biochemical Pharmacology. ,vol. 36, pp. 2065- 2068 ,(1986) , 10.1016/0006-2952(86)90571-X
M. Anwar Waqar, Mary Jo Evans, Kenneth F. Manly, Robert G. Hughes, Joel A. Huberman, Effects of 2',3'-dideoxynucleosides on mammalian cells and viruses. Journal of Cellular Physiology. ,vol. 121, pp. 402- 408 ,(1984) , 10.1002/JCP.1041210218